Literature DB >> 24696111

Identification of intermediate-risk patients with acute symptomatic pulmonary embolism.

Carlo Bova1, Olivier Sanchez2, Paolo Prandoni3, Mareike Lankeit4, Stavros Konstantinides4, Simone Vanni5, David Jiménez6.   

Abstract

The identification of normotensive patients with acute pulmonary embolism (PE) at high risk of adverse PE-related clinical events (i.e. intermediate-risk group) is a major challenge. We combined individual patient data from six studies involving 2874 normotensive patients with PE. We developed a prognostic model for intermediate-risk PE based on the clinical presentation and the assessment of right ventricular dysfunction and myocardial injury. We used a composite of PE-related death, haemodynamic collapse or recurrent PE within 30 days of follow-up as the main outcome measure. The primary outcome occurred in 198 (6.9%) patients. Predictors of complications included systolic blood pressure 90-100 mmHg (adjusted odds ratio (aOR) 2.45, 95% CI 1.50-3.99), heart rate ≥ 110 beats per min (aOR 1.87, 95% CI 1.31-2.69), elevated cardiac troponin (aOR 2.49, 95% CI 1.71-3.69) and right ventricular dysfunction (aOR 2.28, 95% CI 1.58-3.29). We used these variables to construct a multidimensional seven-point risk index; the odds ratio for complications per one-point increase in the score was 1.55 (95% CI 1.43-1.68; p<0.001). The model identified three stages (I, II and III) with 30-day PE-related complication rates of 4.2%, 10.8% and 29.2%, respectively. In conclusion, a simple grading system may assist clinicians in identifying intermediate-risk PE. ©ERS 2014.

Entities:  

Mesh:

Year:  2014        PMID: 24696111     DOI: 10.1183/09031936.00006114

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  33 in total

1.  Comparison of clinical scores for identification of patients with pulmonary embolism at intermediate-high risk of adverse clinical outcome: the prognostic role of plasma lactate.

Authors:  Simone Vanni; Peiman Nazerian; Carlo Bova; Ernesta Bondi; Fulvio Morello; Giuseppe Pepe; Barbara Paladini; Giovanni Liedl; Elisabetta Cangioli; Stefano Grifoni; David Jiménez
Journal:  Intern Emerg Med       Date:  2016-06-28       Impact factor: 3.397

2.  The accuracy of combined use of troponin and red cell distribution width in predicting mortality of patients with acute pulmonary embolism.

Authors:  Selçuk Yazıcı; Tuncay Kırış; Ufuk S Ceylan; Şükrü Akyüz; Ahmet O Uzun; Recep Hacı; Sait Terzi; Abdullah Doğan; Ayşe Emre; Kemal Yeşilçimen
Journal:  Wien Klin Wochenschr       Date:  2016-09-19       Impact factor: 1.704

3.  Impact of relative contraindications to home management in emergency department patients with low-risk pulmonary embolism.

Authors:  David R Vinson; Carrieann E Drenten; Jie Huang; J Eileen Morley; Megan L Anderson; Mary E Reed; Daniel K Nishijima; Vincent Liu
Journal:  Ann Am Thorac Soc       Date:  2015-05

4.  Classification of high-risk with cardiac troponin and shock index in normotensive patients with pulmonary embolism.

Authors:  Savas Ozsu; Muge Erbay; Zerrin Gürel Durmuş; Tevfik Ozlu
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

Review 5.  Risk stratification and management of acute pulmonary embolism.

Authors:  Cecilia Becattini; Giancarlo Agnelli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

6.  Classification and Stratification of Pulmonary Embolisms.

Authors:  Cody Russell; Suresh Keshavamurthy; Sibu Saha
Journal:  Int J Angiol       Date:  2022-09-02

7.  Right ventricular dysfunction is superior and sufficient for risk stratification by a pulmonary embolism response team.

Authors:  Yu Lin Chen; Colin Wright; Anthony P Pietropaoli; Ayman Elbadawi; Joseph Delehanty; Bryan Barrus; Igor Gosev; David Trawick; Dhwani Patel; Scott J Cameron
Journal:  J Thromb Thrombolysis       Date:  2020-01       Impact factor: 2.300

8.  Expert opinion on the creating and operating of the regional Pulmonary Embolism Response Teams (PERT). Polish PERT Initiative.

Authors:  Aleksander Araszkiewicz; Marcin Kurzyna; Grzegorz Kopeć; Marek Roik; Szymon Darocha; Arkadiusz Pietrasik; Mateusz Puślecki; Andrzej Biederman; Roman Przybylski; Jakub Stępniewski; Michał Furdal; Tatiana Mularek-Kubzdela; Piotr Pruszczyk; Adam Torbicki
Journal:  Cardiol J       Date:  2019       Impact factor: 2.737

Review 9.  Risk stratification of patients with acute symptomatic pulmonary embolism.

Authors:  David Jiménez; Jose Luis Lobo; Deisy Barrios; Paolo Prandoni; Roger D Yusen
Journal:  Intern Emerg Med       Date:  2016-01-14       Impact factor: 3.397

10.  One-day experience of pulmonary embolism response team (PERT) during the COVID-19 pandemic: three urgent percutaneous pulmonary embolectomies in acute pulmonary embolism.

Authors:  Andrzej Łabyk; Michał Potępa; Mateusz Jermakow; Michał Machowski; Piotr Pruszczyk; Marek Roik
Journal:  Postepy Kardiol Interwencyjnej       Date:  2021-03-27       Impact factor: 1.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.